Publications
Presentations/Lectures
Publications
Orginal research
1. Confidence Intervals on Microarray Measurement of Differentially Expressed Genes: A Case Study on the effects of MK5, TAF4 and FKRP on the transcriptome. W. Van Belle, N. Gerits, K. Jakobsen,V. Brox, M. Van Ghelue and U. Moens. Gene Regulation and Systems Biology 2007;1:57-72 . Published by LA Press.2. Modulation of F-actin rearrangements by the cyclinc AMP/PKA pathway is mediated by MAPKAP kinase 5 and requires PKA-induced nuclear export of MK5. N. Gerits*, T. Mikalsen*, S. Kostenko, A. Shiryaev, M. Johannessen and U. Moens. Journal of Biological Chemistry 2007;282 (51):37232-43.
3. Transgenic mice expressing constitutive active MK5 display gender-dependent differences on exploration and locomotion. N. Gerits, W. Van Belle and U Moens. Behavioral and Brain Functions 2007;3:58.
4. The transcriptional regulation and cell-specific expression of the MAPK-activated protein kinase MK5. N. Gerits, A. Shiryaev, S. Kostenko, H. Klenow, O. Shiryaeva, M. Johannessen, U. Moens. Cellular and Molecular Biology Letters 2009; 14(4):548-74.
5. Serine residue 115 of MAPK-activated protein kinase MK5 is crucial for its PKA-regulated nuclear export and biological function. S. Kostenko*, A. Shiryaev*, N Gerits, G. Dumitriu, H. Klenow, M. Johannessen, and U. Moens. Cellular and Molecular Life Sciences. 2011 Mar;68(5):847-62.
6. BKV agnoprotein interacts with {$/alpha$}-soluble N-ethylmaleimide-sensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP. M. Johannessen, M. Walquist, N. Gerits, M. Dragset, A. Spang, U. Moens. PLoS One.2011;6(9):e24489.
7. BK polyomavirus with archetypal and rearranged non-coding control regions is present in cerebrospinal fluids from patients with neurological complications. A. Barcena-Panero, JE Echevarria, M. Van Ghelue, G. Fedele, E. Royuela, N. Gerits, U. Moens. J Gen Virol. 2012 Aug;93(Pt 8):1780-94. .
Reviews
1. In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice. N. Gerits, S. Kostenko and U. Moens. Transgenic Research 2007;16(3):281-314. Published by Springer.2. Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: Comradeship and hostility. N. Gerits, S. Kostenko, A. Shiryaev, M. Johannessen, U. Moens. Cellular signalling 2008;20(9):1592-607
3. The roles of mammalian mitogen-activated protein kinase-activating protein kinases (MAPKAPKs) in cell cycle control. S. Kostenko, A. Shiryaev, N. Gerits and U. Moens. Progress in cell cycle control 2008; Chapter 11, p1-25. ISBN: 978-1-60456-797-7. Nova Science Publishers.
4. Emerging polyomaviruses in the human population. U. Moens, M. Johannessen, A. Barcena-Panero, N. Gerits and M. Van Ghelue. Reviews in Infection 2010;1(2):59-93
5. Cross-talk between protein kinase A and the MAPK-activated protein kinases RSK1 and MK5. S. Kostenko, A. Shiryaev, G. Dumitriu, N. Gerits, U. Moens. Journal of Receptors and Signal Transduction. 2011 Feb;31(1):1-9.
6. Agnoprotein of mammalian polyomaviruses. N. Gerits, U. Moens. Virology. 2012 Jun 20
Contributions to book chapters
1. Review: Inhibitors of signal transduction protein kinases as targets for cancer therapy. T. Mikalsen, N. Gerits, and U. Moens. Biotechnology Annual Review 2006:153-223. Published by Elsevier.2. Review: Protein kinase inhibitors. N. Gerits and U. Moens. Encyclopedia of Molecular Pharmacology. 2007;1:1009-1012. ISBN: 978-3-540-38921-7.